Search

everythinglearnresearchcommunity

for

Search:↓

The enzyme RDH12 plays a role in vision and retinal disease, with mutations leading to early onset visual loss and blindness, but the exact disease mechanism is unclear and there are no treatments yet.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

Alkaline ceramidase 1 is crucial for healthy skin and energy balance.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

DGAT1 enzyme helps make diacylglycerols, waxes, and retinyl esters.

A new compound effectively inhibits human 5α-reductase 1.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Cadd4 effectively reduces cholesterol levels without side effects.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Environmental factors affect reproductive traits by altering the SRD5A1 gene.